MDxHealth to Present Fourth Quarter and Full Year 2021 Financial Results and Corporate Update on March 2nd
NEWS RELEASE 17 February 2022, 4:00 PM EST / 22:00 CET MDxHealth to Present Fourth Quarter and Full Year 2021 Financial Results and Corporate Update on March 2nd Company to Host Conference Call with Live Q&A, March 2, 2022 at 4:30pm ET/ 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – February 17, 2022 – MDxHealth […]
MDxHealth to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
NEWS RELEASE9 FEBRUARY 2022, 4:00 PM EST / 22:00 CET MDxHealth to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference IRVINE, CA, and HERSTAL, BELGIUM – February 9, 2022 – MDxHealth SA (NASDAQ/Euronext: MDXH), a commercial-stage precision diagnostics company, today announced that the Company will present at the BTIG MedTech, […]
Déclaration de transparence d’un actionnaire de MDxHealth
COMMUNIQUÉ DE PRESSE – INFORMATION RÉGLEMENTÉE 10 décembre 2021, 23:55 CET Déclaration de transparence d’un actionnaire de MDxHealth IRVINE, CA, et HERSTAL, BELGIQUE – le 10 décembre 2021 – MDxHealth SA (Nasdaq et Euronext Brussels: MDXH) (la “Société” ou “MDxHealth“), une société de diagnostic moléculaire de précision, annonce aujourd’hui conformément à l’article 14 de […]
MDxHealth Shareholder Transparency Declaration
NEWS RELEASE – REGULATED INFORMATION 10 December 2021, 23:55 CET MDxHealth Shareholder Transparency Declaration IRVINE, CA, and HERSTAL, BELGIUM – 10 December 2021 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH) (the “Company” or “MDxHealth“), a commercial-stage precision diagnostics company, announces today in accordance with Article 14 of the Belgian Act of 2 May 2007 […]
Déclarations de Transparence d’Actionnaires de MDxHealth
COMMUNIQUÉ DE PRESSE – INFORMATION RÉGLEMENTÉE 22 novembre 2021, 23:00 CET Déclarations de Transparence d’Actionnaires de MDxHealth IRVINE, CA, et HERSTAL, BELGIQUE – le 22 novembre 2021 – MDxHealth SA (Nasdaq et Euronext Brussels: MDXH) (la “Société” ou “MDxHealth“), une société de diagnostic moléculaire de précision, annonce aujourd’hui conformément à l’article 14 de la […]
MDxHealth Shareholder Transparency Declarations
NEWS RELEASE – REGULATED INFORMATION 22 November 2021, 11:00 p.m. CET MDxHealth Shareholder Transparency Declarations IRVINE, CA, and HERSTAL, BELGIUM – 22 November 2021 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH) (the “Company” or “MDxHealth“), a commercial-stage precision diagnostics company, announces today in accordance with Article 14 of the Belgian Act of 2 May […]
Déclarations de Transparence d’Actionnaires de MDxHealth
COMMUNIQUÉ DE PRESSE – INFORMATION RÉGLEMENTÉE15 novembre 2021, 23 :00 CET Déclarations de Transparence d’Actionnaires de MDxHealth IRVINE, CA, et HERSTAL, BELGIQUE – le 15 novembre 2021 – MDxHealth SA (Nasdaq et Euronext Brussels: MDXH) (la “Société” ou “MDxHealth“), une société de diagnostic moléculaire de précision, annonce aujourd’hui conformément à l’article 14 de la loi du […]
MDxHealth Announces Completion of Initial Public Offering of ADSs in the United States
NEWS RELEASE – REGULATED INFORMATION 15 November 2021, 11:00 p.m. CET MDxHealth Shareholder Transparency Declarations IRVINE, CA, and HERSTAL, BELGIUM – 15 November 2021 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH) (the “Company” or “MDxHealth”), a commercial-stage precision diagnostics company, announces today in accordance with Article 14 of the Belgian Act of 2 May […]
MDxHealth annonce la réalisation de l’offre publique initiale d’ADSs aux Etats-Unis
COMMUNIQUE DE PRESSE – INFORMATION REGLEMENTEE 8 NOVEMBRE 2021, 22:30 CET MDxHealth annonce la réalisation de l’offre publique initiale d’ADSs aux Etats-Unis IRVINE, CA, et HERSTAL, BELGIQUE – 8 novembre 2021 – MDxHealth SA (Nasdaq et Euronext Brussels: MDXH) (“MDxHealth” ou la “Société“), une société de diagnostic de précision à un stade commercial, annonce aujourd’hui, conformément à […]
MDxHealth Announces Completion of Initial Public Offering of ADSs in the United States
NEWS RELEASE – REGULATED INFORMATIONNOVEMBER 8, 2021, 22:30 CET MDxHealth Announces Completion of Initial Public Offering of ADSs in the United States IRVINE, CA, and HERSTAL, BELGIUM – November 8, 2021 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH) (“MDxHealth” or the “Company“), a commercial-stage precision diagnostics company, today announces, in accordance with Article 15 of […]
